DTX1 and small cell lung carcinoma: In contrast, patients with small cell lung cancer (SCLC) carrying DTX1 mutations showed a worse response to chemotherapy and a lower OS rate, suggesting that mutations in the same gene may play opposite roles in different subtypes of malignant tumors in the same organ.